Methylphenidate improves executive functions in patients with traumatic brain injuries: a feasibility trial via the idiographic approach
Authors:
- Samir Al-AdawiSASamir Al-Adawi
- Aziz Al-NaamaniAAAziz Al-Naamani
- Sanjay JajuSJSanjay Jaju
- Yahya M Al-FarsiYAYahya M Al-Farsi
- Atsu S S DorvloADAtsu S S Dorvlo
- Ali Al-MaashaniAAAli Al-Maashani
- Sara S H Al-AdawiSASara S H Al-Adawi
- Ahmed A MoustafaAMAhmed A Moustafa
- Nasser Al-SibaniNANasser Al-Sibani
- Musthafa M EssaMEMusthafa M Essa
- David T BurkeDavid T Burke
- M Walid QoronflehM Walid Qoronfleh
Open Access
- 19 March 2020
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 20 (1) , 1-14
Abstract
Background: Road traffic accidents are known to be the main cause of traumatic brain injury (TBI). TBI is also a leading cause of death and disability. This study, by means of the idiographic approach (single-case experimental designs using multiple-baseline designs), has examined whether methylphenidate (MPH - trade name Ritalin) had a differential effect on cognitive measures among patients with TBI with the sequel of acute and chronic post-concussion syndromes. The effect on gender was also explored. Methods: In comparison with healthy controls, patients with TBI (acute and chronic) and accompanying mild cognitive impairment (MCI) were screened for their integrity of executive functioning. Twenty-four patients exhibiting executive dysfunction (ED) were then instituted with the pharmacological intervention methylphenidate (MPH). The methylphenidate was administered using an uncontrolled, open label design. Results: The administration of methylphenidate impacted ED in the TBI group but had no effect on mood. Attenuation of ED was more apparent in the chronic phases of TBI. The effect on gender was not statistically significant with regard to the observed changes. Conclusions: To our knowledge, this is the first feasibility trial from the Arabian Gulf to report the performance of a TBI population with mild cognitive impairment according to the IQCODE Arabic version. This investigation confirms anecdotal observations of methylphenidate having the potential to attenuate cognitive impairment; particularly those functions that are critically involved in the integrity of executive functioning. The present feasibility trial should be followed by nomothetic studies such as those that adhere to the protocol of the randomized controlled trial. This evidence-based research is the foundation for intervention and future resource allocation by policy- or public health decision-makers.Keywords
This publication has 79 references indexed in Scilit:
- Economic Growth, Motorization, and Road Traffic Injuries in the Sultanate of Oman, 1985–2009Traffic Injury Prevention, 2013
- Moderate Traumatic Brain Injury Triggers Rapid Necrotic Death of Immature Neurons in the HippocampusJournal of Neuropathology & Experimental Neurology, 2012
- The suppression of appetite and food consumption by methylphenidate: the moderating effects of gender and weight status in healthy adultsInternational Journal of Neuropsychopharmacology, 2011
- Global burden of disease in young people aged 10–24 years: a systematic analysisThe Lancet, 2011
- Double dissociation in the anatomy of socioemotional disinhibition and executive functioning in dementia.Neuropsychology, 2011
- Operating Characteristics of Executive Functioning Tests Following Traumatic Brain InjuryThe Clinical Neuropsychologist, 2010
- Quantification of Five Neuropsychological Approaches to Defining Mild Cognitive ImpairmentThe American Journal of Geriatric Psychiatry, 2009
- Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injuryBehavioural Brain Research, 2007
- Individual Differences in Cognitive Planning on the Tower of Hanoi Task: Neuropsychological Maturity or Measurement Error?Journal of Child Psychology and Psychiatry, 2001
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983